type 2 diabetes: the benefits and cost-effectiveness of sglt2 inhibitors
Published 4 years ago • 10K plays • Length 41:04Download video MP4
Download video MP3
Similar videos
-
44:17
cardiovascular disease burden in type 2 diabetes: strategies to improve outcomes
-
22:15
sglt-2 inhibitors for type 2 diabetes - amel arnaout, md
-
55:50
type 2 diabetes: optimizing management within the system of care
-
5:05
sglt2 inhibitors: cv outcomes data in type 2 diabetes
-
5:20
sglt2 inhibition and cvd outcomes in type 2 diabetes
-
1:29:07
optimizing cardiovascular outcomes in type 2 diabetes: beyond a1c goals
-
3:35
sglt-2 inhibitors, explained: how they work, their benefits and risks
-
1:56
diabetes and the role of hormones
-
3:44
sglt2 inhibition in type 1 diabetes patients | john wilding
-
6:58
sglt2 inhibitors in t1d: 'people are using them now'
-
2:27
cardiovascular benefit with sglt2 inhibition
-
8:28
sglt2 inhibitors in patients without diabetes at risk of hf
-
48:43
advancing the quality of diabetes care: achieving glycemic goals while preventing hypoglycemia
-
48:06
diabetes: integrating comprehensive cardiovascular care into patient-centered treatment
-
2:13
cost-effectiveness of sglt2s for cvd
-
25:23
type 2 diabetes - the new epidemic: how did we get here and what's to come?
-
10:37
episode 9 - sodium glucose cotransporter 2 inhibitors and type 2 diabetes mellitus
-
19:56
e97 – harms and benefits of sglt2 inhibitors
-
58:20
what’s new with type 2 diabetes care in 2021 - session 1